Could herbal medicine (Soshihotang) be a new treatment option for COVID-19?: a narrative review

[1]  Jing Liu,et al.  Network pharmacological analysis and mechanism prediction of Xiaochaihu Decoction in treatment of COVID-19 with syndrome of pathogenic heat lingering in lung and obstructive cardinalate/ 小柴胡汤治疗早期新型冠状病毒肺炎（COVID-19）邪热郁肺、枢机不利证功效网络分析与机制预测 , 2020 .

[2]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[3]  Chikin Chan,et al.  SARS-CoV-2 and COVID-19: The most important research questions , 2020, Cell & Bioscience.

[4]  Yang Yang,et al.  Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective , 2020, International journal of biological sciences.

[5]  Jianjun Gao,et al.  Discovering drugs to treat coronavirus disease 2019 (COVID-19). , 2020, Drug discoveries & therapeutics.

[6]  Chao Zhang,et al.  Liver injury in COVID-19: management and challenges , 2020, The Lancet Gastroenterology & Hepatology.

[7]  S. Zhou,et al.  Application of integrative medicine protocols in treatment of coronavirus disease 2019/ 中西医结合治疗新型冠状病毒肺炎的应用分析 , 2020 .

[8]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[9]  C. Akdis,et al.  Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China , 2020, Allergy.

[10]  Nicola Robinson,et al.  Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs , 2020, Chinese Journal of Integrative Medicine.

[11]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[12]  S. Lindstrom,et al.  First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.

[13]  S. Tang,et al.  COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. , 2020, The American journal of Chinese medicine.

[14]  Dao-feng Chen,et al.  In vivo effect of quantified flavonoids-enriched extract of Scutellaria baicalensis root on acute lung injury induced by influenza A virus. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  Jiaguo Liu,et al.  Inhibition mechanisms of baicalin and its phospholipid complex against DHAV-1 replication , 2018, Poultry science.

[16]  J. Dou,et al.  The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity , 2018, Archives of pharmacal research.

[17]  S. Higgs,et al.  Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection , 2018, Antiviral research.

[18]  W. Zhou,et al.  Baicalin benefits the anti‐HBV therapy via inhibiting HBV viral RNAs , 2017, Toxicology and applied pharmacology.

[19]  Erguang Li,et al.  Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice , 2016, Scientific Reports.

[20]  B. Li,et al.  Saikosaponin A inhibits influenza A virus replication and lung immunopathology , 2015, Oncotarget.

[21]  Weifeng Shi,et al.  The Antiviral Effect of Baicalin on Enterovirus 71 In Vitro , 2015, Viruses.

[22]  Ying Liu,et al.  The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb , 2015, Acta pharmaceutica Sinica. B.

[23]  JeongJin-Ju,et al.  Ginsenoside Rb1 Eliminates HIV-1 (D3)-Transduced Cytoprotective Human Macrophages by Inhibiting the AKT Pathway , 2014 .

[24]  A. Yueh,et al.  Baicalin, a metabolite of baicalein with antiviral activity against dengue virus , 2014, Scientific Reports.

[25]  Yousang Baik.  A Study on the Complex Efficacy of Sosihotang , 2014 .

[26]  Soetjipto,et al.  Anti‐hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species , 2014, Microbiology and immunology.

[27]  M. Scheurlen,et al.  [Managing psychiatric side effects of antiviral therapy in chronic hepatitis C]. , 2012, Zeitschrift fur Gastroenterologie.

[28]  Tzou-Yien Lin,et al.  Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. , 2012, Journal of ethnopharmacology.

[29]  L. Gong,et al.  Evolution of preventive treatment's concept from Huangdi's Internal Classic to Treatise on Cold-induced and Miscellaneous Diseases , 2012 .

[30]  A. Vickers,et al.  A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. , 2011, Journal of ethnopharmacology.

[31]  Yong Yang,et al.  Anti-hepatitis B virus activity of wogonin in vitro and in vivo. , 2007, Antiviral research.

[32]  Chun-ching Lin,et al.  Xiao chai hu tang inhibits CVB1 virus infection of CCFS-1 cells through the induction of Type I interferon expression. , 2006, International immunopharmacology.

[33]  Y. Yoshida.  [A non-cardiogenic type of pulmonary edema after administration of Chinese herbal medicine (shosaikoto)--a case report]. , 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[34]  Ji Ming Wang,et al.  Flavonoid baicalin inhibits HIV-1 infection at the level of viral entry. , 2000, Biochemical and biophysical research communications.

[35]  E. Miyazaki,et al.  [Pulmonary edema associated with the Chinese medicine shosaikoto]. , 1998, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[36]  M. Fukushima,et al.  Baicalin, an inhibitor of HIV-1 production in vitro. , 1998, Antiviral research.

[37]  D. Baltimore.  Expression of animal virus genomes. , 1971, Bacteriological reviews.

[38]  Yuanliang Hu,et al.  Assessment of the Effect of Baicalin on Duck Virus Hepatitis. , 2019, Current molecular medicine.

[39]  O. S. Shin,et al.  Wogonin, a flavonoid isolated from Scutellaria baicalensis, has anti-viral activities against influenza infection via modulation of AMPK pathways. , 2018, Acta virologica.

[40]  Hoon Kim,et al.  A study on the Transmutation among Six-channels in Shanghanlun , 2015 .

[41]  Baek Kim,et al.  Ginsenoside Rb1 eliminates HIV-1 (D3)-transduced cytoprotective human macrophages by inhibiting the AKT pathway. , 2014, Journal of medicinal food.

[42]  Liu Kailei,et al.  Immunoregulatory activity of Bupleuri Decoction on the expression of costimulatory molecules on the lymphocytes in immunosuppressed mice. , 2010 .

[43]  弘信 八重樫.  オセルタミビルと比較した A 型インフルエンザに対する麻黄湯・小柴胡湯併用療法の有効性について , 2010 .

[44]  H. Tajiri,et al.  Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. , 1991, The American journal of Chinese medicine.

[45]  M. Furukawa,et al.  Inhibitory effects of kampo medicine on Epstein-Barr virus antigen induction by tumor promoter. , 1990, Auris, nasus, larynx.

[46]  Journal of Traditional and Complementary Medicine , 2022 .

[47]  Harwood Academic Publishers imprint, part of Gordon and Breach Publishing Group Printed in Malaysia Effects of the Japanese Herbal Medicine "Sho-saiko-to" (TJ-9) on Interleukin-12 Production in Patients with HC-Positive Liver Cirrhosis , 2022 .